sk&f 82958 has been researched along with 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Dimattio, K; Li, JG; Liu-Chen, LY; Unterwald, E; Wang, Y; Xu, W | 1 |
1 other study(ies) available for sk&f 82958 and 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide
Article | Year |
---|---|
PKA and ERK1/2 are involved in dopamine D₁ receptor-induced heterologous desensitization of the δ opioid receptor.
Topics: Animals; Benzamides; Benzazepines; Blotting, Western; Cell Line; CHO Cells; Cocaine; Cricetinae; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; MAP Kinase Signaling System; Mice; Phosphorylation; Piperazines; Rats; Receptors, Dopamine D1; Receptors, Opioid, delta | 2013 |